A Phase 3 study to evaluate the safety, Tolerability, and immunogenicity of a Catch Up vaccine in healthy children and adolescents. Ages ≥ 15 months to <18 years old.
PG4-C4931008
A Phase 3 study to evaluate the safety, Tolerability, and immunogenicity of a multivalent…
